Frontlight ResearchEarly access
Haemophilia trials in South Korea
4 of 10 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
- Where
- Seoul, Ulsan
- Age
- 18 years and over
- People
- 11
- Run by
- Takeda
See details and how to joinNCT06550882 - No phaseTaking peopleA Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A
- Where
- Multiple Locations
- Age
- 12 years and over
- People
- 20
- Run by
- Bayer
See details and how to joinNCT06222697 - Phase 4Enrolling by invitationA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Seoul
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseEnrolling by invitationDefeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
- Where
- Seoul
- People
- 244 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07163260